Enveric Biosciences, Inc.

NASDAQ (USD): Enveric Biosciences, Inc. (ENVB)

Last Price

0.961

Today's Change

+0.051 (5.60%)

Day's Change

0.92 - 0.961

Trading Volume

27,232

Overview

Market Cap

7 Million

Shares Outstanding

7 Million

Avg Volume

4,504,352

Avg Price (50 Days)

1.03

Avg Price (200 Days)

1.76

PE Ratio

-0.12

EPS

-8.09

Earnings Announcement

13-May-2024

Previous Close

0.91

Open

0.95

Day's Range

0.9201 - 0.97

Year Range

0.649 - 6.98

Trading Volume

52,221

Price Change Highlight

1 Day Change

6.56%

5 Day Change

-2.02%

1 Month Change

-19.17%

3 Month Change

-24.22%

6 Month Change

-53.37%

Ytd Change

-23.02%

1 Year Change

-27.07%

3 Year Change

-99.26%

5 Year Change

-99.94%

10 Year Change

-99.99%

Max Change

-100.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment